Description
Technical & Manufacturing Relevance:
Pancrelipase is a highly standardized pancreatic enzyme preparation used primarily for fat digestion, with supportive activity for carbohydrates and proteins. It is widely used in pharmaceutical and specialized medical nutrition formulations for managing exocrine pancreatic insufficiency (EPI) and severe digestive malabsorption. Compared to pancreatin, pancrelipase has higher and more consistent lipase activity, making it suitable for targeted fat-digestion support. Acid sensitivity necessitates enteric protection to ensure enzymatic activity in the small intestine.
Applicable Dosage Forms:
Enteric-coated capsules, Delayed-release pellets or microspheres, Enteric-coated tablets, Medical nutrition formulations
Pharmacopoeial / Quality Notes:
Supplied with precisely defined enzyme activity (especially lipase units), uniform particle size for consistent intestinal release, and strict impurity control. Manufactured in compliance with USP/EP/BP pharmacopoeial standards. In many countries, pancrelipase is regulated as a prescription medicine rather than a dietary supplement; regulatory status and usage permissions vary by country and must be verified prior to formulation and marketing.
Manufacturing Support:
We provide bulk enzyme sourcing, activity-based grade selection, enteric-coating and delayed-release technology support, formulation customization (where legally permitted), and contract/third-party manufacturing with complete COA, MSDS, stability, enzyme-activity, microbial & heavy-metal documentation, enabling compliant resale and worldwide distribution as per destination-country regulatory requirements.
